Literature DB >> 23745834

Morphological changes in eosinophils are reliable markers of the severity of an acute asthma exacerbation in children.

M I Muniz-Junqueira1, S M Barbosa-Marques, L F Junqueira.   

Abstract

BACKGROUND: Early identification of the severity of asthma exacerbation would be helpful for the management of patients. We aimed to evaluate the correlation of morphological change in activated eosinophils and the severity of an asthma exacerbation.
METHODS: Blood was collected from 55 asthmatic children: 40 of whom were having an exacerbation, 15 symptom-free, and 15 healthy controls. The percentage of eosinophils with morphological changes (emission of single or multiple pseudopods, presence of cytoplasmic vacuoles, releasing a small, moderate, or large quantity of granules, spreading, eosinophil death, and presence of cluster of free eosinophil granules) was quantified after the adherence to a slide and compared using the Mann-Whitney test. The correlation between the severity of the asthma exacerbation and the percentage changed eosinophils was tested with Spearman's correlation.
RESULTS: The proportion of activated eosinophils was higher in asthmatic symptom-free children than in the control group, and acute asthma exacerbation produced an additional increase in eosinophil activation (P < 0.01). More significantly increased morphological changes were emissions of multiple pseudopods, presence of cytoplasmic vacuoles, spreading, and presence of a cluster of free eosinophil granules (P < 0.001). The following were correlated with the severity of an asthma exacerbation: ≥14% of eosinophils emitting single pseudopod, 8% emitting multiple pseudopods, 17% with vacuoles, 28% eosinophils releasing a large quantity of granules, and 66% of spread eosinophils.
CONCLUSIONS: Quantifying the morphological changes in eosinophils is a feasible, easy, and reliable manner to identify the severity of an asthma exacerbation and therefore might improve the clinical management of asthmatic children.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  activated eosinophils; acute asthma exacerbation; asthma; eosinophil morphological changes

Mesh:

Substances:

Year:  2013        PMID: 23745834     DOI: 10.1111/all.12176

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

Review 1.  Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation.

Authors:  Shigeharu Ueki; Takahiro Tokunaga; Shigeharu Fujieda; Kohei Honda; Makoto Hirokawa; Lisa A Spencer; Peter F Weller
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

2.  Primary lysis of eosinophils as a major mode of activation of eosinophils in human diseased tissues.

Authors:  Carl Persson; Lena Uller
Journal:  Nat Rev Immunol       Date:  2013-12       Impact factor: 53.106

3.  Eosinophil Shape Change and Secretion.

Authors:  Sergei I Ochkur; Elizabeth A Jacobsen; Paige Lacy
Journal:  Methods Mol Biol       Date:  2021

4.  Interleukin-13 in Asthma and Other Eosinophilic Disorders.

Authors:  Emma Doran; Fang Cai; Cécile T J Holweg; Kit Wong; Jochen Brumm; Joseph R Arron
Journal:  Front Med (Lausanne)       Date:  2017-09-19

5.  Atomic Force Microscopy Is a Potent Technique to Study Eosinophil Activation.

Authors:  Peter Eaton; Constança Pais do Amaral; Shirley C P Couto; Mariangela S Oliveira; Andreanne G Vasconcelos; Tatiana K S Borges; Selma A S Kückelhaus; José Roberto S A Leite; Maria Imaculada Muniz-Junqueira
Journal:  Front Physiol       Date:  2019-10-01       Impact factor: 4.566

6.  Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis.

Authors:  Teppei Hashimoto; Shigeharu Ueki; Yosuke Kamide; Yui Miyabe; Mineyo Fukuchi; Yuichi Yokoyama; Tetsuya Furukawa; Naoto Azuma; Nobuyuki Oka; Hiroki Takeuchi; Kyoko Kanno; Akemi Ishida-Yamamoto; Masami Taniguchi; Akira Hashiramoto; Kiyoshi Matsui
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

7.  Inhaled corticosteroid treatment for 6 months was not sufficient to normalize phagocytosis in asthmatic children.

Authors:  Carmen Lívia Faria da Silva-Martins; Shirley Claudino Couto; Maria Imaculada Muniz-Junqueira
Journal:  Clin Transl Allergy       Date:  2013-08-30       Impact factor: 5.871

Review 8.  How to detect eosinophil ETosis (EETosis) and extracellular traps.

Authors:  Mineyo Fukuchi; Yui Miyabe; Chikako Furutani; Tomoo Saga; Yuki Moritoki; Takechiyo Yamada; Peter F Weller; Shigeharu Ueki
Journal:  Allergol Int       Date:  2020-11-12       Impact factor: 7.478

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.